Completed
Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy
NCT00419341
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
- Locations
-
- Study Site Los Angeles, California, United States
- Study Site Los Angeles, California, United States
- Study Site Centennial, Colorado, United States
- Study Site North Palm Beach, Florida, United States